China Biologic Products Holdings Inc. (CBPO)

71.00
1.25 1.73
NASDAQ : Health Technology
Prev Close 72.25
Open 72.64
Day Low/High 70.65 / 73.74
52 Wk Low/High 71.84 / 107.44
Volume 152.03K
Avg Volume 294.50K
Exchange NASDAQ
Shares Outstanding 37.27M
Market Cap 2.71B
EPS 2.40
P/E Ratio 30.57
Div & Yield N.A. (N.A)

Latest News

Leading Investor Group Issues Statement Following China Biologic's Dilutive Private Placement Of Shares

Leading Investor Group Issues Statement Following China Biologic's Dilutive Private Placement Of Shares

A consortium composed of Mr. David (Xiaoying) Gao, GL Capital Group, Bank of China Group Investment Limited and CDH Investments (the "Consortium") today issued the following statement following China Biologic Products Holdings, Inc.

China Biologic Announces Updates On Unsolicited Acquisition Proposals And Strategic Private Placement

China Biologic Announces Updates On Unsolicited Acquisition Proposals And Strategic Private Placement

BEIJING, Aug. 24, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc.

China Biologic Announces Receipt Of Competing Non-Binding Acquisition Proposal

China Biologic Announces Receipt Of Competing Non-Binding Acquisition Proposal

BEIJING, Aug. 21, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc.

Leading Investor Group Proposes To Acquire China Biologic Products For US$118.00 Per Share In Cash

Leading Investor Group Proposes To Acquire China Biologic Products For US$118.00 Per Share In Cash

A consortium composed of Mr. David (Xiaoying) Gao, GL Capital Group, Bank of China Group Investment Limited and CDH Investments (the "Consortium") today announced it has made a non-binding proposal to acquire all of the outstanding common shares of China...

China Biologic Names Bing Li As New CEO

China Biologic Names Bing Li As New CEO

BEIJING, Aug. 13, 2018 /PRNewswire/ --  China Biologic Products Holdings, Inc.

CBPO Crosses Above Average Analyst Target

CBPO Crosses Above Average Analyst Target

In recent trading, shares of China Biologic Products Holdings Inc have crossed above the average analyst 12-month target price of $96.00, changing hands for $97.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

China Biologic Reports Financial Results For The Second Quarter Of 2018

China Biologic Reports Financial Results For The Second Quarter Of 2018

-- 2Q18 Total Sales Up 25.5% YoY and Non-GAAP Adjusted Net Income Down 2.

China Biologic Products To Report Second Quarter 2018 Financial Results

China Biologic Products To Report Second Quarter 2018 Financial Results

BEIJING, July 27, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release...

China Biologic Announces Results Of Its 2018 Annual General Meeting Of Shareholders

China Biologic Announces Results Of Its 2018 Annual General Meeting Of Shareholders

BEIJING, July 2, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced the results of the Company's 2018 Annual...

China Biologic Announces Receipt Of Non-Binding Acquisition Proposal

China Biologic Announces Receipt Of Non-Binding Acquisition Proposal

BEIJING, June 19, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("CBPO" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its board of directors (the "Board")...

WeissLaw LLP Investigates China Biologic Products Holdings, Inc.

WeissLaw LLP Investigates China Biologic Products Holdings, Inc.

NEW YORK, June 18, 2018 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of China Biologic Products Holdings, Inc.

China Biologic Receives CFDA Clinical Trial Approval For Human Fibrin Sealant

China Biologic Receives CFDA Clinical Trial Approval For Human Fibrin Sealant

BEIJING, June 11, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that Shandong Taibang Biological...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CCRN, CNSL, CWST, GPS, KRA, PSTG, RBA, SEM, SWN, WPX Downgrades: CBPO, CPLA, GBLI, HPT, INXN, LGND, MCC, NRG, PEP, XOXO Initiations: LAUR Read on to get TheStreet Quant Ratings' detailed report:

Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio

Chinese Plasma Maker China Biologic a Solid Addition for a Portfolio

This little-known, Beijing-based drug company is benefiting from accelerating demand for blood substitutes.

Today's Perilous Reversal Stock: China Biologic Products (CBPO)

Today's Perilous Reversal Stock: China Biologic Products (CBPO)

Trade-Ideas LLC identified China Biologic Products (CBPO) as a "perilous reversal" (up big yesterday but down big today) candidate

Strong On High Relative Volume: China Biologic Products (CBPO)

Strong On High Relative Volume: China Biologic Products (CBPO)

Trade-Ideas LLC identified China Biologic Products (CBPO) as a strong on high relative volume candidate

Insider Trading Alert - UUUU, ZAYO And CBPO Traded By Insiders

Insider Trading Alert - UUUU, ZAYO And CBPO Traded By Insiders

Stocks with insider trader activity include UUUU, ZAYO and CBPO

China Biologic Products (CBPO) Highlighted as Today's Perilous Reversal Stock

China Biologic Products (CBPO) Highlighted as Today's Perilous Reversal Stock

Trade-Ideas LLC identified China Biologic Products (CBPO) as a "perilous reversal" (up big yesterday but down big today) candidate

Today's Water-Logged And Getting Wetter Stock: China Biologic Products (CBPO)

Today's Water-Logged And Getting Wetter Stock: China Biologic Products (CBPO)

Trade-Ideas LLC identified China Biologic Products (CBPO) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate

New Lifetime High Today: China Biologic Products (CBPO)

New Lifetime High Today: China Biologic Products (CBPO)

Trade-Ideas LLC identified China Biologic Products (CBPO) as a new lifetime high candidate

Trade-Ideas: China Biologic Products (CBPO) Is Today's New Lifetime High Stock

Trade-Ideas: China Biologic Products (CBPO) Is Today's New Lifetime High Stock

Trade-Ideas LLC identified China Biologic Products (CBPO) as a new lifetime high candidate

China Biologic Products (CBPO) Highlighted As Today's Perilous Reversal Stock

China Biologic Products (CBPO) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified China Biologic Products (CBPO) as a "perilous reversal" (up big yesterday but down big today) candidate

China Biologic Products (CBPO) Hits New Lifetime High Today

China Biologic Products (CBPO) Hits New Lifetime High Today

Trade-Ideas LLC identified China Biologic Products (CBPO) as a new lifetime high candidate

Today's Strong And Under The Radar Stock Is China Biologic Products (CBPO)

Today's Strong And Under The Radar Stock Is China Biologic Products (CBPO)

Trade-Ideas LLC identified China Biologic Products (CBPO) as a strong and under the radar candidate

China Biologic Products (CBPO) Marked As A Dead Cat Bounce Stock

China Biologic Products (CBPO) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified China Biologic Products (CBPO) as a "dead cat bounce" (down big yesterday but up big today) candidate

China Biologic Products (CBPO) Showing Signs Of Perilous Reversal Today

China Biologic Products (CBPO) Showing Signs Of Perilous Reversal Today

Trade-Ideas LLC identified China Biologic Products (CBPO) as a "perilous reversal" (up big yesterday but down big today) candidate

Insider Trading Alert - SSE, CBPO And PLAB Traded By Insiders

Insider Trading Alert - SSE, CBPO And PLAB Traded By Insiders

Stocks with insider trader activity include SSE, CBPO and PLAB

Blood Money -- This Plasma Maker Is Set to Soar

Blood Money -- This Plasma Maker Is Set to Soar

Looking for companies that make essential products? China Biologic Products is tapping a rich vein of profits by making a must-have commodity: human blood.

TheStreet Quant Rating: C (Hold)